INGREZZA® (valbenazine) capsules is an FDA-approved treatment for adults with the uncontrollable movements of tardive dyskinesia (TD).
INGREZZA is proven to reduce uncontrollable body movements from tardive dyskinesia (TD)
In a clinical study, about 70% of patients taking INGREZZA 80 mg saw reduction in TD movements at 6 weeks*
- This post-clinical study evaluation included 70 patients taking INGREZZA 80 mg, measuring uncontrollable movements before starting treatment and at 6 weeks of treatment.
*Patients had at least a 1-point reduction on an uncontrollable movement severity scale at 6 weeks vs before treatment.